I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

Q4 2024 Earnings Call Transcript February 13, 2025 DexCom, Inc. misses on earnings expectations. Reported EPS is $0.45 EPS, expectations were $0.4792. Operator: Thank you for standing by. My name is ...

Annual Results/Quarter Results Strong 2024 performance reflects Straumann Group’s strengths in innovation and execution 19-Feb-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art.

We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to ... causing disease in patients with multiple sclerosis, type 1 diabetes, and ...

Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...

Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ETCompany ParticipantsJoe Di Salvo – Vice President-Treasurer ...

Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa., Feb. 13, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its ...

SAN DIEGO, February 13, 2025--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a ...